双管功能障碍预测ST升高心肌梗塞患者心脏性冲击患者的死亡率
Angga Dwi Prasetyo1, Hendry Purnasidha Bagaswoto2, Firandi Saputra1
1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Jalan Farmako Sekip Utara, Yogyakarta, 55281, Indonesia.
概括
双功能障碍在经历心脏性休克的ST升高心肌梗塞 (STEMI) 患者中显著增加了住院死亡风险. 其他死亡预测因素包括衰竭和血管压缩剂的使用.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 临床研究 临床研究
背景情况:
- 由于ST升高心肌梗塞 (STEMI) 的心脏性休克死亡率仍然很高,尽管进行了再输血治疗.
- 静脉缩功能障碍是STEMI中心脏性休克的主要原因.
- 虽然左和右心室功能障碍已被研究,但双心室功能障碍对死亡率的预测价值尚不清楚.
研究的目的:
- 为了评估心脏性休克的STEMI患者中双心脏静脉缩功能障碍的死亡率预测值.
- 在这个患者群体中确定住院死亡率的关键预测因素.
主要方法:
- 使用Sardjito心血管重症监护 (SCIENCE) 登记册进行的回顾性队列研究.
- 数据是在2021年11月至2023年9月期间在萨尔德吉托医生总医院收集的.
- 多变量逻辑回归分析以评估住院死亡率的预测因素.
主要成果:
- 双功能障碍 (BVD) 显著增加了住院死亡的风险 (OR,1.771;p=0.016).
- 其他显著的死亡预测因素包括功能衰竭 (OR,5.122;p<0.001) 和因诺托普/血管压缩剂的使用 (OR,6.876;p<0.001).
- 穿皮冠状动脉干预 (PCI) 与死亡率降低有关 (OR,0.493;p=0.044).
结论:
- 双功能障碍是心脏性休克的STEMI患者住院死亡率的重要独立预测因素.
- 功能衰竭和需要无otropic或血管压缩剂的支持是影响死亡率的关键因素.
- 在这种群体中,PCI可能在降低死亡率方面发挥保护作用.
相关概念视频
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Cardiac Output II: Effect of Stroke Volume on Cardiac Output
652
Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
652
01:26Heart Failure Drugs: Inotropic Agents
515
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
515